Not available
Quote | Bison Capital Acquisition Corp. (NASDAQ:BCAC)
Last: | $22.71 |
---|---|
Change Percent: | 114.65% |
Open: | $10.07 |
Close: | $10.58 |
High: | $27.74 |
Low: | $9.94 |
Volume: | 540,270 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Bison Capital Acquisition Corp. (NASDAQ:BCAC)
Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports and conference presentat...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due t...
Message Board Posts | Bison Capital Acquisition Corp. (NASDAQ:BCAC)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Bison Capital Acquisition Corp. Company Name:
BCAC Stock Symbol:
NASDAQ Market:
SAN CARLOS, Calif., July 11, 2022 (GLOBE NEWSWIRE) -- Apexigen, Inc. (“Apexigen”), a clinical-stage company focused on developing innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology, today announced that Apexigen’s Manageme...
SAN CARLOS, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- Apexigen, Inc. (“Apexigen”), a clinical-stage company focused on developing innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology, today announced the appointment of William Duke...
- Data from the Parker Institute for Cancer Immunotherapy and Cancer Research Institute multi-center Phase 2 PRINCE trial demonstrated that novel circulating and tumor biomarkers may be predictive of overall survival - - Identified distinct immune responses and biomarkers in...